IE911381A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: IE911381A1
Authority: IE; Ireland
Prior art keywords: wafer; composition according; medicament; sub; lingual
Prior art date: 1990-04-26

Application number

IE138191A

Other languages

English (en)

Original Assignee

Smith Kline French Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-26

Filing date

1991-04-25

Publication date

1991-11-06

1991-04-25 Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab

1991-11-06 Publication of IE911381A1 publication Critical patent/IE911381A1/en

Links

239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 7
239000003814 drug Substances 0.000 claims abstract description 43
210000004877 mucosa Anatomy 0.000 claims abstract description 12
239000000203 mixture Substances 0.000 claims description 26
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 claims description 14
229960001597 nifedipine Drugs 0.000 claims description 14
102000055006 Calcitonin Human genes 0.000 claims description 9
108060001064 Calcitonin Proteins 0.000 claims description 9
229920002472 Starch Polymers 0.000 claims description 9
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical group N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims description 9
239000008107 starch Substances 0.000 claims description 8
235000019698 starch Nutrition 0.000 claims description 8
229960004015 calcitonin Drugs 0.000 claims description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
240000007594 Oryza sativa Species 0.000 claims description 5
235000007164 Oryza sativa Nutrition 0.000 claims description 5
238000010521 absorption reaction Methods 0.000 claims description 5
235000009566 rice Nutrition 0.000 claims description 5
102000002265 Human Growth Hormone Human genes 0.000 claims description 4
108010000521 Human Growth Hormone Proteins 0.000 claims description 4
239000000854 Human Growth Hormone Substances 0.000 claims description 4
239000003995 emulsifying agent Substances 0.000 claims description 3
239000000314 lubricant Substances 0.000 claims description 3
239000000546 pharmaceutical excipient Substances 0.000 claims description 3
210000003296 saliva Anatomy 0.000 claims description 3
239000003623 enhancer Substances 0.000 claims description 2
230000002708 enhancing effect Effects 0.000 claims description 2
239000000796 flavoring agent Substances 0.000 claims description 2
235000013355 food flavoring agent Nutrition 0.000 claims description 2
230000036571 hydration Effects 0.000 claims description 2
238000006703 hydration reaction Methods 0.000 claims description 2
230000002209 hydrophobic effect Effects 0.000 claims description 2
239000003921 oil Substances 0.000 claims description 2
239000007787 solid Substances 0.000 claims description 2
235000012431 wafers Nutrition 0.000 description 50
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
238000000034 method Methods 0.000 description 5
239000002552 dosage form Substances 0.000 description 4
DDPFHDCZUJFNAT-PZPWKVFESA-N chembl2104402 Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 DDPFHDCZUJFNAT-PZPWKVFESA-N 0.000 description 3
108700032313 elcatonin Proteins 0.000 description 3
229960000756 elcatonin Drugs 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
239000002002 slurry Substances 0.000 description 3
239000007921 spray Substances 0.000 description 3
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
101000741447 Gallus gallus Calcitonin Proteins 0.000 description 2
244000068988 Glycine max Species 0.000 description 2
235000010469 Glycine max Nutrition 0.000 description 2
SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
AUJRCFUBUPVWSZ-XTZHGVARSA-M auranofin Chemical compound CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O AUJRCFUBUPVWSZ-XTZHGVARSA-M 0.000 description 2
229960005207 auranofin Drugs 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
229940079593 drug Drugs 0.000 description 2
VSHJAJRPRRNBEK-LMVCGNDWSA-N eel calcitonin Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C1=CN=CN1 VSHJAJRPRRNBEK-LMVCGNDWSA-N 0.000 description 2
229960003711 glyceryl trinitrate Drugs 0.000 description 2
LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
210000002200 mouth mucosa Anatomy 0.000 description 2
229960002715 nicotine Drugs 0.000 description 2
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000002904 solvent Substances 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
239000006190 sub-lingual tablet Substances 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
239000008158 vegetable oil Substances 0.000 description 2
206010002383 Angina Pectoris Diseases 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
KSIYPKPZIBBUFR-LJNLPFSOSA-N CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O Chemical compound CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O KSIYPKPZIBBUFR-LJNLPFSOSA-N 0.000 description 1
101100533230 Caenorhabditis elegans ser-2 gene Proteins 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
206010012373 Depressed level of consciousness Diseases 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
101000741445 Homo sapiens Calcitonin Proteins 0.000 description 1
235000019759 Maize starch Nutrition 0.000 description 1
101000910296 Ovis aries Calcitonin Proteins 0.000 description 1
-1 Polyethylene Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
101000910301 Rattus norvegicus Calcitonin Proteins 0.000 description 1
244000061456 Solanum tuberosum Species 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
101000910302 Sus scrofa Calcitonin Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
208000003443 Unconsciousness Diseases 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000005030 aluminium foil Substances 0.000 description 1
229960003773 calcitonin (salmon synthetic) Drugs 0.000 description 1
239000002775 capsule Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
TVURRHSHRRELCG-UHFFFAOYSA-N fenoldopam Chemical compound C1=CC(O)=CC=C1C1C2=CC(O)=C(O)C(Cl)=C2CCNC1 TVURRHSHRRELCG-UHFFFAOYSA-N 0.000 description 1
229960002724 fenoldopam Drugs 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
238000007429 general method Methods 0.000 description 1
229940074774 glycyrrhizinate Drugs 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940045644 human calcitonin Drugs 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
238000002386 leaching Methods 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000006186 oral dosage form Substances 0.000 description 1
229940094443 oxytocics prostaglandins Drugs 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
108010068072 salmon calcitonin Proteins 0.000 description 1
238000006884 silylation reaction Methods 0.000 description 1
238000005507 spraying Methods 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
229940100445 wheat starch Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IE138191A 1990-04-26 1991-04-25 Pharmaceutical compositions IE911381A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909009390A GB9009390D0 (en)	1990-04-26	1990-04-26	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
IE911381A1 true IE911381A1 (en)	1991-11-06

Family

ID=10675032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IE138191A IE911381A1 (en)	1990-04-26	1991-04-25	Pharmaceutical compositions

Country Status (15)

Country	Link
EP (1)	EP0526524B1 (de)
JP (1)	JPH05506655A (de)
AT (1)	ATE131383T1 (de)
AU (1)	AU649041B2 (de)
CA (1)	CA2081109A1 (de)
DE (1)	DE69115476T2 (de)
DK (1)	DK0526524T3 (de)
ES (1)	ES2080314T3 (de)
GB (1)	GB9009390D0 (de)
GR (1)	GR3019298T3 (de)
IE (1)	IE911381A1 (de)
NZ (1)	NZ237930A (de)
PT (1)	PT97476B (de)
WO (1)	WO1991016041A1 (de)
ZA (1)	ZA913072B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5700478A (en) *	1993-08-19	1997-12-23	Cygnus, Inc.	Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
ATE252373T1 (de) *	1994-08-04	2003-11-15	Elan Drug Delivery Ltd	Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
WO1996035516A1 (en)	1995-05-09	1996-11-14	Colorcon Limited	Electrostatic coating
US7008668B2 (en)	1995-05-09	2006-03-07	Phoqus Pharmaceuticals Limited	Powder coating composition for electrostatic coating of pharmaceutical substrates
DE19646392A1 (de)	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GB9623634D0 (en)	1996-11-13	1997-01-08	Bpsi Holdings Inc	Method and apparatus for the coating of substrates for pharmaceutical use
WO1999055341A1 (en) *	1998-04-27	1999-11-04	Elan Pharmaceuticals, Inc.	Transdermal administration of fenoldopam
US6699497B1 (en)	1998-07-24	2004-03-02	Alza Corporation	Formulations for the transdermal administration of fenoldopam
ATE269063T1 (de) *	1998-07-24	2004-07-15	Alza Corp	Formulierungen zur transdermalen verabreichung von fenoldopam
AU3884900A (en) *	1999-03-18	2000-10-04	Quing Non Yng-Wong	Wafer delivery system
US6583160B2 (en) *	1999-04-14	2003-06-24	Steve Smith	Nicotine therapy method and oral carrier for assuaging tobacco-addiction
USRE42126E1 (en)	1999-07-02	2011-02-08	The Procter & Gamble Company	Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
GB0002305D0 (en)	2000-02-01	2000-03-22	Phoqus Limited	Power material for electrostatic application
IT1318618B1 (it) *	2000-07-10	2003-08-27	A C R Applied Coating Res S A	Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
US8524200B2 (en)	2002-09-11	2013-09-03	The Procter & Gamble Company	Tooth whitening products
BRPI0415741B1 (pt)	2003-11-07	2013-07-23		composições de tabaco e métodos de fabricação de uma composição de tabaco
US8627828B2 (en)	2003-11-07	2014-01-14	U.S. Smokeless Tobacco Company Llc	Tobacco compositions
GB0407312D0 (en)	2004-03-31	2004-05-05	Phoqus Pharmaceuticals Ltd	Method and apparatus for the application of powder material to substrates
DE102008014533A1 (de) *	2008-03-15	2009-09-17	Lts Lohmann Therapie-Systeme Ag	Gingival-Wafer
US20090276040A1 (en)	2008-05-01	2009-11-05	Edwards Lifesciences Corporation	Device and method for replacing mitral valve
EP2358297B1 (de)	2008-11-21	2019-09-11	Percutaneous Cardiovascular Solutions Pty Limited	Herzklappenprothese
CA2961053C (en)	2009-04-15	2019-04-30	Edwards Lifesciences Cardiaq Llc	Vascular implant and delivery system
NZ596179A (en)	2009-04-29	2014-05-30	Cleveland Clinic Foundation	Apparatus and method for replacing a diseased cardiac valve
US9730790B2 (en)	2009-09-29	2017-08-15	Edwards Lifesciences Cardiaq Llc	Replacement valve and method
US8449599B2 (en)	2009-12-04	2013-05-28	Edwards Lifesciences Corporation	Prosthetic valve for replacing mitral valve
WO2012040655A2 (en)	2010-09-23	2012-03-29	Cardiaq Valve Technologies, Inc.	Replacement heart valves, delivery devices and methods
US12502276B2 (en)	2011-05-16	2025-12-23	Edwards Lifesciences Corporation	Inversion delivery device and method for a prosthesis
PL2908798T3 (pl)	2012-10-17	2019-02-28	Procter & Gamble	Pasek do wprowadzania środka aktywującego higienę jamy ustnej i sposoby stosowania środków aktywujących higienę jamy ustnej
US9439763B2 (en)	2013-02-04	2016-09-13	Edwards Lifesciences Corporation	Prosthetic valve for replacing mitral valve
US20140277427A1 (en)	2013-03-14	2014-09-18	Cardiaq Valve Technologies, Inc.	Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9532870B2 (en)	2014-06-06	2017-01-03	Edwards Lifesciences Corporation	Prosthetic valve for replacing a mitral valve
RU2017114607A (ru)	2014-09-28	2018-10-29	Кардиокинетикс, Инк.	Устройства для терапии нарушений функции сердца
CN106999281B (zh)	2014-11-26	2020-05-05	爱德华兹生命科学公司	经导管人工心脏瓣膜和递送系统
WO2016153918A1 (en)	2015-03-20	2016-09-29	Cardiokinetix, Inc.	Systems and methods for delivering an implantable device
US10441416B2 (en)	2015-04-21	2019-10-15	Edwards Lifesciences Corporation	Percutaneous mitral valve replacement device
US10350062B2 (en)	2016-07-21	2019-07-16	Edwards Lifesciences Corporation	Replacement heart valve prosthesis
CN109843219B (zh)	2016-08-26	2022-04-05	爱德华兹生命科学公司	多部分置换心脏瓣膜假体
CA3067150A1 (en)	2017-07-06	2019-01-10	Edwards Lifesciences Corporation	Steerable rail delivery system
CN111818877B (zh)	2018-01-25	2023-12-22	爱德华兹生命科学公司	在部署后用于辅助置换瓣膜重新捕获和重新定位的递送系统
EP4789707A2 (de) *	2018-11-09	2026-08-12	Janssen Biotech, Inc.	Arzneimittelabgabevorrichtungen, systeme und verfahren zur lokalen arzneimittelabgabe in den oberen harntrakt
JP7381601B2 (ja)	2019-04-12	2023-11-15	エドワーズライフサイエンシーズコーポレイション	マルチパートフレーム及び関連するレジリエントブリッジ特徴部を備えた弁
CN113924066B (zh)	2019-04-23	2026-04-14	爱德华兹生命科学公司	电动植入物递送系统
JP2021147362A (ja) *	2020-03-23	2021-09-27	学校法人常翔学園	舌下投与用ゼリー剤
WO2022132569A1 (en)	2020-12-18	2022-06-23	Edwards Lifesciences Corporation	Storage jar assembly for aprosthetic heart valve
CN118302132A (zh)	2021-10-27	2024-07-05	爱德华兹生命科学公司	用于卷曲和装载假体心脏瓣膜的系统和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE871821C (de) *	1950-10-24	1953-03-26	Curt Angelmi	Traeger fuer Arzneimittel oder aehnliche dem Koerper einzuverleibende Stoffe
GB2022999A (en) *	1978-06-17	1979-12-28	Culpitt & Son Ltd G	Paper compositions incorporating medicaments
GB2085299A (en) *	1980-10-09	1982-04-28	English Grains Ltd	Treating sores using wafer-like carrier with active ingredients
CH653550A5 (de) *	1981-10-20	1986-01-15	Sandoz Ag	Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS6185315A (ja) *	1984-10-04	1986-04-30	Teikoku Seiyaku Kk	シ−ト状製剤

1990
- 1990-04-26 GB GB909009390A patent/GB9009390D0/en active Pending
1991
- 1991-04-24 DE DE69115476T patent/DE69115476T2/de not_active Expired - Fee Related
- 1991-04-24 NZ NZ237930A patent/NZ237930A/xx unknown
- 1991-04-24 ZA ZA913072A patent/ZA913072B/xx unknown
- 1991-04-24 AU AU77481/91A patent/AU649041B2/en not_active Ceased
- 1991-04-24 AT AT91908384T patent/ATE131383T1/de not_active IP Right Cessation
- 1991-04-24 EP EP91908384A patent/EP0526524B1/de not_active Expired - Lifetime
- 1991-04-24 ES ES91908384T patent/ES2080314T3/es not_active Expired - Lifetime
- 1991-04-24 WO PCT/GB1991/000651 patent/WO1991016041A1/en not_active Ceased
- 1991-04-24 CA CA002081109A patent/CA2081109A1/en not_active Abandoned
- 1991-04-24 PT PT97476A patent/PT97476B/pt not_active IP Right Cessation
- 1991-04-24 JP JP91507944A patent/JPH05506655A/ja active Pending
- 1991-04-24 DK DK91908384.0T patent/DK0526524T3/da active
- 1991-04-25 IE IE138191A patent/IE911381A1/en unknown
1996
- 1996-03-13 GR GR960400702T patent/GR3019298T3/el unknown

Also Published As

Publication number	Publication date
AU7748191A (en)	1991-11-11
NZ237930A (en)	1993-08-26
EP0526524A1 (de)	1993-02-10
AU649041B2 (en)	1994-05-12
EP0526524B1 (de)	1995-12-13
GR3019298T3 (en)	1996-06-30
WO1991016041A1 (en)	1991-10-31
CA2081109A1 (en)	1991-10-27
PT97476B (pt)	1998-08-31
DE69115476T2 (de)	1996-06-05
JPH05506655A (ja)	1993-09-30
ZA913072B (en)	1992-11-25
DK0526524T3 (da)	1996-01-29
GB9009390D0 (en)	1990-06-20
ES2080314T3 (es)	1996-02-01
DE69115476D1 (de)	1996-01-25
PT97476A (pt)	1992-01-31
ATE131383T1 (de)	1995-12-15

Publication	Publication Date	Title
AU649041B2 (en)	1994-05-12	Pharmaceutical compositions
US4470962A (en)	1984-09-11	Polymeric diffusion matrix
US5514673A (en)	1996-05-07	Pharmaceutical composition containing lipophilic drugs
RU2460519C2 (ru)	2012-09-10	Биоразрушаемый пластырь
EP0665755B1 (de)	1998-07-01	Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
KR101595139B1 (ko)	2016-02-17	치은 웨이퍼
KR101089049B1 (ko)	2011-12-02	친지성 약물의 제형
AU2002246916B2 (en)	2006-06-08	Bioadhesive cell foam film of sustained-release delivery
CN1142771C (zh)	2004-03-24	条带型延长释放药物剂型
US20080275030A1 (en)	2008-11-06	Methods and Compositions for the Delivery of a Therapeutic Agent
WO2002020037A1 (fr)	2002-03-14	Composition pharmaceutique a administration orale liberee au niveau colique
JP2009185078A (ja)	2009-08-20	動物用及びヒト用医薬における活性物質の投与用の、粘膜接着性を有し、崩壊可能な医薬品調合剤
NO920357L (no)	1992-07-29	Tilberedning for kontrollert frigivelse av virksomme stoffer, som er egnet som terapeutikum eller for forbedring avveksten og forutnyttelsen hos droevtyggere
KR20060126701A (ko)	2006-12-08	경피 또는 국소 약물 전달에 따른 원치않는 효과의치료방법
EP3150230A1 (de)	2017-04-05	Verfahren und zusammensetzungen zur abgabe eines therapeutischen mittels
JP2740465B2 (ja)	1998-04-15	経皮投与のための新規薬理投与形態
CN1469707A (zh)	2004-01-21	改进的疏水性药物的固体药物剂量制剂
JP2009521532A (ja)	2009-06-04	活性物質を放出するための、ｐＨ調節されたフィルム
EA002197B1 (ru)	2002-02-28	Препараты левозимендана, предназначенные для введения через слизистую оболочку
KR830001816B1 (ko)	1983-09-12	중합형 확산성 매트릭스의 제조방법
US11213491B2 (en)	2022-01-04	Film-like form of administration for the transmucosal delivery of antidiabetic peptides
AU2683492A (en)	1993-05-03	Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl
WO2011137491A1 (en)	2011-11-10	Novel drug delivery system
EP1515706A2 (de)	2005-03-23	Plattform für transdermale formulierungen (ptf)
CN1164272C (zh)	2004-09-01	含有川芎嗪的组合物以及川芎嗪透皮贴剂及其制备方法